Daily News Podcast

Alarming rate of diabetes medication discontinuations


 

Most patients with type 2 diabetes stop taking their medication within a year, and nearly one-third stop within the first 3 months. Also today, the FDA approves Ajovy for migraine prevention, some teens are using cannabis in their vapor devices, and alpha-blocker use is still common and still risky.


Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Lung function decline linked to cardiovascular risk
MDedge Endocrinology
Rivaroxaban beats aspirin for VTE
MDedge Endocrinology
FDA approval for 2 HIV drugs
MDedge Endocrinology
Modest alcohol and NAFLD
MDedge Endocrinology
Cardiovascular risk with diclofenac
MDedge Endocrinology
Baloxavir, oseltamivir similar for influenza
MDedge Endocrinology
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Endocrinology
Review protocols, follow reprocessing guidelines to cut device-related HAIs
MDedge Endocrinology
CDC opens Emergency Operations Center in advance of Hurricane Florence
MDedge Endocrinology
Urine drug screens show improper medication use
MDedge Endocrinology